HCPCS Code Details - J9326

HCPCS Level II Code
Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J9326
Description

Long description:
Injection, telisotuzumab vedotin-tllv, 1 mg

Short description:
Telisotuzumab vedotin-tllv

HCPCS Modifier1
HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1D - Chemotherapy
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2026
Date added Added Jan 01, 2026
HCPCS Coding Procedures

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
NU” identifies the hospital bed as new equipment

ASP Drug pricing - J9326

Effective Code Dosage Payment
Limit
Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
April 1, 2026 - June 30, 2026 1 MG 145.994 - - - - - -
January 1, 2026 - March 31, 2026 1 MG 145.871 - - - - - -

See also

  • HCPCS J9325 · Injection, talimogene laherparepvec, per 1 million plaque forming units

  • HCPCS C9306 · Injection, telisotuzumab vedotin-tllv, 1 mg

  • HCPCS J9328 · Injection, temozolomide, 1 mg


1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”